Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial | Zendy

Marie-Claude Morice | Zendy; Patrick W. Serruys | Zendy; A. Pieter Kappetein | Zendy; Ted Feldman | Zendy; Elisabeth Ståhle | Zendy; Antonio Colombo | Zendy; Michael J. Mack | Zendy; David R. Holmes | Zendy; James W. Choi | Zendy; Witold Rużyłło | Zendy; Grzegorz Religa | Zendy; Jian Huang | Zendy; Kristine Roy | Zendy; Keith D. Dawkins | Zendy; Friedrich W. Mohr | Zendy

Open Access

Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial

Author(s) -

Marie-Claude Morice,

Patrick W. Serruys,

A. Pieter Kappetein,

Ted Feldman,

Elisabeth Ståhle,

Antonio Colombo,

Michael J. Mack,

David R. Holmes,

James W. Choi,

Witold Rużyłło,

Grzegorz Religa,

Jian Huang,

Kristine Roy,

Keith D. Dawkins,

Friedrich W. Mohr

Publication year - 2014

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.113.006689

Subject(s) - medicine , conventional pci , percutaneous coronary intervention , hazard ratio , cardiology , coronary artery disease , confidence interval , mace , surgery , revascularization , stroke (engine) , myocardial infarction , mechanical engineering , engineering

Current guidelines recommend coronary artery bypass graft surgery (CABG) when treating significant de novo left main coronary artery (LM) stenosis; however, percutaneous coronary intervention (PCI) has a class IIa indication for unprotected LM disease in selected patients. This analysis compares 5-year clinical outcomes in PCI- and CABG-treated LM patients in the Synergy Between PCI With Taxus and Cardiac Surgery (SYNTAX) trial, the largest trial in this group to date.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research